IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 115

Article Submitted : 19445

Article Published : 8041

Total Authors : 21252

Total Reviewer : 769

Total Countries : 144

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: CRISPR-Cas9: Opportunities and Challenges in the Therapeutic Landscape of Leukemia
Authors Name: Jalormi Vora , Urjita Sanghavi
Download E-Certificate: Download
Author Reg. ID:
IJRTI_207095
Published Paper Id: IJRTI2510139
Published In: Volume 10 Issue 10, October-2025
DOI:
Abstract: Leukemia, a heterogeneous group of hematologic malignancies originating from aberrant proliferation of hematopoietic stem and progenitor cells, remains one of the leading causes of cancer-related morbidity and mortality worldwide. Despite significant progress in chemotherapy, radiotherapy, hematopoietic stem cell transplantation (HSCT), and immunotherapeutic approaches, disease relapse and therapy resistance continue to present major obstacles to long-term remission. The emergence of the clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein 9 (Cas9) system has revolutionized genome editing, offering a simple, precise, and programmable tool for targeted gene manipulation. CRISPR-Cas9 has been applied extensively to dissect leukemogenic pathways, identify novel oncogenic drivers, and develop innovative therapeutic strategies, including gene correction, immunotherapy enhancement, and synthetic lethality screening. However, its translation into clinical oncology remains challenged by off-target mutagenesis, delivery inefficiencies, ethical considerations, and regulatory barriers. This review critically examines the mechanistic principles of CRISPR-Cas9, its therapeutic potential in leukemia, and the evolving landscape of CRISPR-based clinical research, while highlighting future prospects such as base editing, prime editing, and Cas variants that may improve safety and precision.
Keywords: CRISPR-Cas9; Leukemia; Genome editing; Immunotherapy; Gene correction; Off-target effects; Cancer therapeutics
Cite Article: "CRISPR-Cas9: Opportunities and Challenges in the Therapeutic Landscape of Leukemia", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.10, Issue 10, page no.b318-b332, October-2025, Available :http://www.ijrti.org/papers/IJRTI2510139.pdf
Downloads: 00075
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2510139
Registration ID:207095
Published In: Volume 10 Issue 10, October-2025
DOI (Digital Object Identifier):
Page No: b318-b332
Country: Bhavnagar, Gujarat, India
Research Area: Biological Science
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2510139
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2510139
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner